Drawing for ACE IMMUNOID PLATFORM

USPTO serial 88057824

ACE IMMUNOID PLATFORM

Reviewed by CopyMark Law Group

Reg. 5713474Status 710
Filing date
Status date
Registration date
Apr 2, 2019
Examiner
NEHMER, JASON ROBERT
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with ACE IMMUNOID PLATFORM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Laura C. Miller

Laura C. Miller Kilpatrick Townsend & Stockton LLP1001 West Fourth StreetWinston-Salem, NC 27101UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Providing genome sequencing, data analysis and interpretation, assay development and preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules, and research and design relating thereto, all in the field of bioinformatics, genomics and gene expression research and developmentSECTION 8 - CANCELLEDOct 8, 2015
044Analysis of cells, tissues, gene expressions, gene sequences, genome annotation, transcriptome characterization, and genome mapping for medical diagnosis and treatment; Preparation of reports relating to gene expressions, gene and genome sequences, genome interaction and annotation, transcriptome analysis and characterization, and genome mapping for medical diagnosis and treatmentSECTION 8 - CANCELLEDOct 8, 2015

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 17, 2025C8..CANCELLED SEC. 8 (6-YR)—
Apr 2, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Sep 24, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 24, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 24, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 2, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 15, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 15, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 26, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 7, 2018ALIEASSIGNED TO LIE—
Nov 19, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 19, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Nov 19, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 19, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 19, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 15, 2018DOCKASSIGNED TO EXAMINER—
Aug 3, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 2, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance